Critical Role of AZI2 in GM-CSF–Induced Dendritic Cell Differentiation
暂无分享,去创建一个
Osamu Takeuchi | Kenta Maruyama | Toshihiko Okazaki | Shizuo Akira | Tatsukata Kawagoe | S. Akira | O. Takeuchi | T. Satoh | S. Uematsu | Tatsuya Kozaki | Satoshi Uematsu | Takashi Satoh | Kenta Maruyama | Takashi Mino | Sarang Tartey | Takashi Mino | Masahiro Fukasaka | Daisuke Ori | Tatsuya Kozaki | Tomoko Imamura | T. Okazaki | Sarang Tartey | T. Kawagoe | D. Ori | M. Fukasaka | Tomoko Imamura
[1] P. Fisher,et al. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. , 2011, Cancer research.
[2] A. Iwasaki,et al. Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.
[3] Markus G. Manz,et al. Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.
[4] M. Yoneyama,et al. NAK-Associated Protein 1 Participates in Both the TLR3 and the Cytoplasmic Pathways in Type I IFN Induction1 , 2006, The Journal of Immunology.
[5] R. Steinman,et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.
[6] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[7] M. White,et al. RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival , 2006, Cell.
[8] S. Akira,et al. Cutting Edge: Role of TANK-Binding Kinase 1 and Inducible IκB Kinase in IFN Responses against Viruses in Innate Immune Cells1 , 2006, The Journal of Immunology.
[9] M. Clare-Salzler,et al. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases , 2009 .
[10] Li Wu,et al. Cutting Edge: Generation of Splenic CD8+ and CD8− Dendritic Cell Equivalents in Fms-Like Tyrosine Kinase 3 Ligand Bone Marrow Cultures1 , 2005, The Journal of Immunology.
[11] C. Rooney,et al. Enhancement of dendritic cells as vaccines for cancer. , 2010, Immunotherapy.
[12] Eric S. Lander,et al. Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene , 2007, Cell.
[13] M. Kapsenberg. Dendritic-cell control of pathogen-driven T-cell polarization , 2003, Nature Reviews Immunology.
[14] T. Mak,et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF‐κB‐dependent gene transcription , 2000, The EMBO journal.
[15] T. Taniguchi,et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. , 2000, Immunity.
[16] Karolina Palucka,et al. Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.
[17] M. White,et al. TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. , 2011, Molecules and Cells.
[18] S. Akira,et al. Akt Contributes to Activation of the TRIF-Dependent Signaling Pathways of TLRs by Interacting with TANK-Binding Kinase 1 , 2011, The Journal of Immunology.
[19] A. Shahangian,et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.
[20] G. Cheng,et al. Modulation of the Interferon Antiviral Response by the TBK1/IKKi Adaptor Protein TANK* , 2007, Journal of Biological Chemistry.
[21] K. Honda,et al. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. , 2006, Immunity.
[22] M. Nakanishi,et al. Cutting Edge: NF-κB-Activating Kinase-Associated Protein 1 Participates in TLR3/Toll-IL-1 Homology Domain-Containing Adapter Molecule-1-Mediated IFN Regulatory Factor 3 Activation1 , 2005, The Journal of Immunology.
[23] Ruslan Medzhitov,et al. Transcriptional control of the inflammatory response , 2009, Nature Reviews Immunology.
[24] M. Yoneyama,et al. RNA recognition and signal transduction by RIG‐I‐like receptors , 2009, Immunological reviews.
[25] A. Dunn,et al. The influence of granulocyte/macrophage colony‐stimulating factor on dendritic cell levels in mouse lymphoid organs , 1997, European journal of immunology.
[26] Young Keun Kim,et al. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. , 2011, Nature nanotechnology.
[27] Ira Mellman,et al. Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.
[28] T. Taniguchi,et al. Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-α/β Gene Induction , 2000 .
[29] S. Akira,et al. Endotoxin-Induced Maturation of MyD88-Deficient Dendritic Cells1 , 2001, The Journal of Immunology.
[30] M. Karin,et al. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. , 2003, Molecular and cellular biology.
[31] Donald Metcalf,et al. Hematopoietic cytokines. , 2008, Blood.
[32] W. Heath,et al. Dendritic cell subsets in primary and secondary T cell responses at body surfaces , 2009, Nature Immunology.
[33] J. O’Shea,et al. IFN Regulatory Factor-4 and -8 Govern Dendritic Cell Subset Development and Their Functional Diversity , 2005, The Journal of Immunology.
[34] F. Randow,et al. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1‐binding domain with NAP1 and TANK , 2007, The EMBO journal.
[35] K. Ishii,et al. A New Subset of CD103+CD8α+ Dendritic Cells in the Small Intestine Expresses TLR3, TLR7, and TLR9 and Induces Th1 Response and CTL Activity , 2011, The Journal of Immunology.
[36] Angel F. Lopez,et al. Mechanism of Activation of the GM‐CSF, IL‐3, and IL‐5 Family of Receptors , 1998, Stem cells.
[37] G. Superti-Furga,et al. Functional Dissection of the TBK1 Molecular Network , 2011, PloS one.
[38] S. Akira,et al. TRAF Family Member-associated NF-κB Activator (TANK) Is a Negative Regulator of Osteoclastogenesis and Bone Formation* , 2012, The Journal of Biological Chemistry.
[39] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[40] M. Karin,et al. Identification of NAP1, a Regulatory Subunit of IκB Kinase-Related Kinases That Potentiates NF-κB Signaling , 2003, Molecular and Cellular Biology.
[41] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[42] A. Celada,et al. Deacetylase Activity Is Required for STAT5-Dependent GM-CSF Functional Activity in Macrophages and Differentiation to Dendritic Cells1 , 2008, The Journal of Immunology.
[43] M. Dottore,et al. The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation , 2008, Cell.
[44] H. Ueno,et al. Recent Developments in Cancer Vaccines , 2011, The Journal of Immunology.
[45] K. Nakai,et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.
[46] K. Honda,et al. Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors , 2006 .
[47] S. Akira,et al. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis , 2009 .
[48] S. Akira,et al. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. , 2011, Immunity.
[49] Bali Pulendran,et al. Translating Innate Immunity into Immunological Memory: Implications for Vaccine Development , 2006, Cell.
[50] Hideo Negishi,et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.
[51] A. Miyajima,et al. Critical cytoplasmic domains of the common beta subunit of the human GM‐CSF, IL‐3 and IL‐5 receptors for growth signal transduction and tyrosine phosphorylation. , 1992, The EMBO journal.
[52] E. Unanue,et al. Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity , 2008, Science.